Aurobindo Pharma financials at a glance

+ Portfolio

The revenue of Aurobindo Pharma is reported as 284.1443 billion Rupees in the fiscal year 2024. The earnings were 53.51 Rupees per share in 2024, which was 29.85 lower than 2022. And about 36.05481 billion Rupees are reported as free cash flow in the financials of Aurobindo Pharma 2024. Dividends of 4.79 Rupees per share were paid to shareholders of Aurobindo Pharma stock NSEI:AUROPHARMA in fiscal 2024.

Rp248.55B

Revenue

Rp32.90

Earnings Per Share

52.30%

Gross Margin %

Rp-3,225.60M

Free Cash Flow

Revenue

248,553.80

Earnings Per Share

32.90

Gross Margin %

52.30

Free Cash Flow

-3,225.60

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Rev.	Revenue	N/A	Rp248.55B	Rp234.55B	Rp247.75B	Rp230.99B	Rp195.64B	Rp165.00B	Rp150.90B	Rp138.96B	Rp121.21B	Rp81.00B	Rp58.55B	Rp46.27B	Rp43.81B	Rp35.75B	Rp29.66B	Rp24.36B	Rp22.50B	Rp16.96B	Rp14.17B
GM %	Gross Margin %	52.53%	52.30%	55.45%	58.87%	56.58%	54.16%	57.92%	56.76%	55.36%	53.17%	45.81%	37.50%	34.49%	40.05%	40.85%	35.52%	31.37%	29.28%	25.22%	25.08%
OM	Operating Margin	11.64%	10.27%	14.10%	17.98%	17.06%	16.93%	19.82%	20.43%	20.45%	18.91%	23.68%	12.57%	9.55%	19.00%	19.88%	14.06%	11.79%	10.53%	7.14%	5.10%
EPS	Earnings Per Share	Rp39.61	Rp32.90	Rp46.90	Rp56.15	Rp47.98	Rp41.51	Rp41.36	Rp39.33	Rp33.92	Rp27.00	Rp20.11	Rp5.05	Rp3.40	Rp8.95	Rp8.92	Rp1.54	Rp3.53	Rp3.03	Rp1.25	Rp0.06
Div.	Dividends	N/A	Rp3.00	Rp4.50	Rp4.00	Rp3.00	Rp2.50	Rp2.50	Rp2.50	Rp2.50	Rp4.50	Rp1.50	Rp0.50	Rp0.50	Rp1.00	Rp0.50	Rp0.45	Rp0.33	Rp0.25	Rp0.15	Rp0.50
PR %	Payout Ratio %	0	9.12%	9.59%	7.12%	6.25%	6.02%	6.04%	6.36%	7.37%	16.67%	7.46%	9.90%	14.71%	11.17%	5.61%	29.22%	9.35%	8.25%	12.00%	833.33%
Sha.	Shares	N/AM	585.94M	585.94M	585.94M	585.94M	585.92M	585.91M	585.88M	585.17M	583.96M	582.91M	582.42M	582.24M	582.24M	557.29M	537.65M	537.65M	533.49M	532.7M	507.7M
OCF	Operating Cash Flow	N/A	Rp23.87B	Rp50.16B	Rp33.29B	Rp43.81B	Rp16.22B	Rp19.55B	Rp32.79B	Rp17.60B	Rp12.37B	Rp6.46B	Rp2.75B	Rp3.26B	Rp3.43B	Rp4.29B	Rp0.00M	Rp1.59B	Rp186.50M	Rp0.00M	Rp0.00M
FCF	Free Cash Flow	N/A	Rp-3,225.60M	Rp29.64B	Rp18.91B	Rp29.99B	Rp1.96B	Rp4.25B	Rp15.84B	Rp1.91B	Rp46.85B	Rp2.56B	Rp16.10M	Rp-2,451.10M	Rp-3,725.50M	Rp88.50M	Rp0.00M	Rp-,875.70M	Rp-3,132.20M	Rp0.00M	Rp0.00M
FCFS	Free Cash Flow Per Share	Rp-27.39	Rp-5.69	Rp39.46	Rp24.83	Rp50.35	Rp1.57	Rp7.25	Rp27.07	Rp-2.50	Rp8.03	Rp4.39	Rp0.03	Rp-4.21	Rp-6.63	Rp0.10	Rp-6.45	Rp-0.93	Rp-5.88	Rp-3.93	Rp-4.07

Aurobindo Pharma financials at a glance

Financials

Discover